# Local Phase 4 Pan-European SMART Study

> **NCT00463866** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 8424 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Budesonide/formoterol

## Key facts

- **NCT ID:** NCT00463866
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** —
- **Final completion:** 2008-12
- **Target enrollment:** 8424 (ACTUAL)
- **Last updated:** 2010-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00463866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00463866, "Local Phase 4 Pan-European SMART Study". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00463866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*